Literature DB >> 22139885

The peptide derived from erbB2 auto-inhibitor herstatin shared in the same epitope and function with functional antibody 2C4.

Ming Lv1, Chunxia Qiao, Nan Jiang, Xinying Li, Ming Yu, Chunmei Hou, Yan Li, Jiannan Feng, Beifen Shen.   

Abstract

Previous studies have shown that different epitopes of HER2 exhibit distinct functions and that the epitope bound by the antibody 2C4 plays a role in formation of hetereodimers between HER2 and other receptors of the HER family. In this study, we used computer modeling to determine that the epitope of HER2 which the C-terminal 79 amino acids of herstatin (named HSTC79) binds is similar to that bound by 2C4. Based on these theoretical results, recombinant HSTC79 fused with GST was expressed in Escherichia coli and purified by affinity chromatography. Experimental analysis showed that HSTC79 did specifically bind to HER2 and that the epitope of HER2 identified by HSTC79 was near that identified by 2C4. Furthermore, HSTC79 inhibited the growth of HER2-overexpressing cells. These results highlight the fact that the binding site architecture and certain key residues of HER2 may be very helpful for understanding the protein's biological role and providing insights for designing novel inhibitors of HER2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22139885     DOI: 10.1007/s12033-011-9454-y

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  22 in total

1.  Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor.

Authors:  N G Azios; F J Romero; M C Denton; J K Doherty; G M Clinton
Journal:  Oncogene       Date:  2001-08-23       Impact factor: 9.867

Review 2.  The epidermal growth factor receptor as a target for cancer therapy.

Authors:  J Mendelsohn
Journal:  Endocr Relat Cancer       Date:  2001-03       Impact factor: 5.678

3.  Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.

Authors:  Julia A Staverosky; Leslie L Muldoon; Shuhua Guo; Adam J Evans; Edward A Neuwelt; Gail M Clinton
Journal:  Clin Cancer Res       Date:  2005-01-01       Impact factor: 12.531

4.  Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.

Authors:  Quincey A Justman; Gail M Clinton
Journal:  J Biol Chem       Date:  2002-04-04       Impact factor: 5.157

5.  Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling.

Authors:  Peter Mullen; David A Cameron; Max Hasmann; John F Smyth; Simon P Langdon
Journal:  Mol Cancer Ther       Date:  2007-01       Impact factor: 6.261

Review 6.  Targeting HER1/EGFR: a molecular approach to cancer therapy.

Authors:  Carlos Arteaga
Journal:  Semin Oncol       Date:  2003-06       Impact factor: 4.929

7.  The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells.

Authors:  Rita Nahta; Mien-Chie Hung; Francisco J Esteva
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

8.  Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway.

Authors:  Kazuko Sakai; Hideyuki Yokote; Kimiko Murakami-Murofushi; Tomohide Tamura; Nagahiro Saijo; Kazuto Nishio
Journal:  Cancer Sci       Date:  2007-07-11       Impact factor: 6.716

9.  All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired.

Authors:  J Baulida; M H Kraus; M Alimandi; P P Di Fiore; G Carpenter
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

Review 10.  Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer.

Authors:  Christina H Yeon; Mark D Pegram
Journal:  Invest New Drugs       Date:  2005-10       Impact factor: 3.651

View more
  1 in total

1.  Intron-Encoded Domain of Herstatin, An Autoinhibitor of Human Epidermal Growth Factor Receptors, Is Intrinsically Disordered.

Authors:  Daisuke Tashiro; Shunji Suetaka; Nao Sato; Koji Ooka; Tomoko Kunihara; Hisashi Kudo; Junichi Inatomi; Yuuki Hayashi; Munehito Arai
Journal:  Front Mol Biosci       Date:  2022-05-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.